Full text is available at the source.
Abstract
Tirzepatide is approved in the US for the treatment of Type 2 diabetes, weight loss, and obstructive sleep apnoea.
- Tirzepatide may be effective for managing Type 2 diabetes.
- The drug is associated with potential weight loss benefits.
- Its use could impact individuals with obstructive sleep apnoea.
- The study evaluates tirzepatide's utilization within a large US commercially insured population.
Simplified